Evidence map›Paper›PMID 29861624›Full record

ArticleDrug design, development and therapy2018

Design and preparation of derivatives of oleanolic and glycyrrhetinic acids with cytotoxic properties.

Rui Wang, Yang Li, Xu-Dong Huai, Qing-Xuan Zheng, Wei Wang, Hui-Jing Li, Qi-Yong Huai

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui Wang *Marine College, Shandong University, Weihai, China.
Yang Li *Zhong Yuan Academy of Biological Medicine, Liaocheng People's Hospital/Affiliated Liaocheng Hospital, Taishan Medical University, Liaocheng, China.
Xu-Dong HuaiSchool of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao, China.
Qing-Xuan ZhengMarine College, Shandong University, Weihai, China.
Wei WangMarine College, Shandong University, Weihai, China.
Hui-Jing LiSchool of Marine Science and Technology, Harbin Institute of Technology at Weihai, Weihai, China.
Qi-Yong HuaiMarine College, Shandong University, Weihai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe structural modification of natural products with the aim to improve the anticancer activity is a popular current research direction. The pentacyclic triterpenoid compounds oleanolic acid (OA) and glycyrrhetinic acid (GA) are distributed widely in nature.

methodsIn this study, various oleanolic acids and glycyrrhetinic acids were designed and synthesized by using the combination principle. The in vitro anticancer activities of new OA and GA derivatives were tested by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) method with SGC-7901 (gastric cancer), MCF-7 (breast cancer), Eca-109 (esophageal cancer), HeLa (cervical cancer), Hep-G2 (hepatoma cancer) and HSF (normal human skin fibroblast) cells. RESULTS AND

conclusionThe screening results showed that the compound

Indexed as

Drug DesignAntineoplastic Agents, PhytogenicApoptosisCell LineCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorGlycyrrhetinic AcidHumansMolecular StructureOleanolic AcidStructure-Activity RelationshipAntineoplastic Agents, PhytogenicGlycyrrhetinic AcidOleanolic Acidapoptosiscytotoxic propertiesglycyrrhetinic acidoleanolic acidsynthesis

Identifiers

PMID29861624
PMCPMC5968802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.